Page last updated: 2024-10-22

albuterol and Anthracosilicosis

albuterol has been researched along with Anthracosilicosis in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Anthracosilicosis: A form of pneumoconiosis caused by inhalation of dust that contains both CARBON and crystalline SILICON DIOXIDE. These foreign matters induce fibrous nodule formation in the lung.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Levitskaia, VL1

Other Studies

1 other study available for albuterol and Anthracosilicosis

ArticleYear
[Role of pneumotachography in the diagnosis and assessment of treatment effectiveness in bronchial dystonia in respiratory tract diseases of dust etiology].
    Terapevticheskii arkhiv, 1988, Volume: 60, Issue:3

    Topics: Administration, Inhalation; Albuterol; Anthracosilicosis; Bronchial Diseases; Coal Mining; Drug Eval

1988